A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Heart Center and Gene Therapy Unit, Kuopio University Hospital, Kuopio, Finland.
Methods Mol Biol. 2022;2573:179-187. doi: 10.1007/978-1-0716-2707-5_14.
NOGA/MyoStar system uses low magnetic fields and endomyocardial electrical parameters, allowing precise endomyocardial injections of therapeutic agents to ischemic yet viable myocardium which is most likely to respond to the treatment. Preclinical and clinical studies have shown that NOGA/MyoStar guided intramyocardial injections are safe, feasible and a minimally invasive way to deliver gene therapy to the heart. Here we describe how to perform electroanatomical mapping and injections to hibernating myocardium in the preclinical studies.
NOGA/MyoStar 系统采用低磁场和心内膜电参数,可将治疗药物精确注射到缺血但有活力的心肌中,这些心肌最有可能对治疗产生反应。临床前和临床研究表明,NOGA/MyoStar 引导的心内膜内注射是一种安全、可行且微创的方法,可将基因治疗递送到心脏。在这里,我们描述了如何在临床前研究中进行电解剖映射和冬眠心肌注射。